Pharmaxis has conducted a number of clinical trials as part of the regulatory approvals process for Bronchitol.
|Description||Five Year Post Authorisation Safety Study of Bronchitol (Inhaled Mannitol) in the UK|
|Sites||UK Patient Registry|
|Description||CF303: Treatment of adults with Cystic Fibrosis|
|Sites||126 Sites in Europe , Australia, Middle East, New Zealand, North America, Russia, South Africa, South America|
* ClinicalTrials.gov is a service provided by the U.S. National Institutes of Health, Department of Health and Human Services, through its National Library of Medicine. ClinicalTrials.gov provides patients, family members, and members of the public easy and free access to information on clinical studies for a wide range of diseases and conditions. Pharmaxis chooses to publish all Pivotal Trials on the ClinicalTrials.gov website.
*** No further clinical development planned in Bronchiectasis